Skip to content

Clinical trials

Completed Phase 2 Neoplasms by Site trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Phase: Phase 2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20082
20091
20102
20111
20122
20141
20161
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Steba Biotech S.A.2
Eli Lilly and Company1
Faculdade de Medicina do ABC1
Merck KGaA, Darmstadt, Germany1
Novartis Pharmaceuticals1
Revolution Medicines, Inc.1
Susanne Crocamo1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms16
Neoplasms by Site16
Carcinoma8
Digestive System Diseases4
Digestive System Neoplasms4
Breast Diseases3
Breast Neoplasms3
Colonic Diseases3
Colorectal Neoplasms3
Gastrointestinal Diseases3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.